Inari Medical Inc

Inari Medical Inc(NARI)股票分析

$79.970

+0.040 (+0.05%)收盤時

Loading chart…
最高
79.990
開盤
79.970
成交量加權均價
79.97
成交量
2.36M
市值
2.73B
最低
79.960
成交金額
188.66M
企業價值/稅息折舊攤銷前利潤(TTM)
243.88

Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss.

估值指標

Inari Medical Inc(NARI)目前預期本益比為 305.46,5 年平均預期本益比為 4.32。

預期本益比

合理
5 年均值 P/E
4.32
目前P/E
305.46
高估
459.08
低估
-450.45

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
356.68
目前EV/EBITDA
243.88
高估
1728.75
低估
-1015.39

預期股價營收比

合理
5 年均值 P/S
7.33
目前P/S
6.60
高估
10.04
低估
4.63

NARI 常見問題 —— 由 Alphio AI 解答

Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易